NeuroEchos

About NeuroEchos

NeuroEchos, officially known as NeuroEchos Medical (Shenzhen) Co., Ltd., is a high-tech enterprise established in Shenzhen, China, in 2017. The company was founded by a team of leading talents from diverse fields including high-end medical devices, artificial intelligence, big data, clinical functional neurosurgery, and brain science. The founder is Mr. Yang Huan. NeuroEchos focuses on providing integrated diagnosis and treatment solutions for diseases caused by abnormal nervous system discharges, with a particular emphasis on functional neurosurgery and precision medicine.

The company operates in the medical device and monitoring equipment industry, developing and producing Class II and Class III hardware. Its business model revolves around the research, development, manufacturing, and sales of advanced neuro-medical products. A key component of their strategy includes robust research and development, evidenced by their 2,000-square-meter clean production and R&D space in Shenzhen. NeuroEchos has established numerous collaborations with top universities and research institutions, including Zhejiang University and UCLA, to advance research in brain science and artificial intelligence, forming joint labs to facilitate these efforts.

The flagship product is a 3.0T MRI-compatible Stereoelectroencephalography (SEEG) deep brain electrode, a device used for the diagnosis of refractory epilepsy. This product, which received NMPA approval in July 2024, is significant as it broke a two-decade-long international monopoly in the field. The SEEG electrodes are designed for precision, featuring all-platinum-iridium alloy construction and improved coating and welding processes to achieve a leading signal-to-noise ratio for EEG signal acquisition. The company also offers AI-assisted decision-making software to help diagnose and accurately interpret EEG waves. Since its inception, NeuroEchos has successfully completed five rounds of venture capital financing, raising a total of $20.3 million from investors such as Sunland Fund, Co-Power Capital Management, and Shenzhen Gaoxin Investment.